Synapep BPC-157 is available for purchase from AIMx Podiatry
For other products, visit AIMxPodiatry.com or reach us at
For other products, visit AIMxPodiatry.com or reach us at
Introducing SynaPep™ BPC-157 as the next-generation oral peptide therapy formulated to accelerate soft tissue recovery, reduce inflammation, and promote full-foot function—without injections or complicated protocols.
Other BPC-157 oral peptides dissolve prematurely because they don’t have our patented delivery system.
Our patented lactoferrin system protects BPC-157 through digestion, delivering superior absorption and bioavailability.
Our patented lactoferrin delivery system protects the peptide through the stomach to provide superior delivery and absorption.
Foot and ankle injuries involve stubborn inflammation and slow-healing tissues. SynaPep BPC-157 supports healing by improving angiogenesis, enhancing fibroblast activity, and reducing inflammatory cytokines—optimizing outcomes when combined with PRP or biologics.
Unlike standard oral peptides, SynaPep BPC-157 uses a patented lactoferrin-based delivery system that protects the peptide through the digestive tract and enhances absorption via the oral and intestinal mucosa. This means greater bioavailability, faster action, and real clinical results—in a convenient single-dose oral sachet.
of soft tissue, ligaments & tendons
and strengthens repair
for faster comfort and mobility
to injured sites
for stronger, longer-lasting results
— ideal for post-surgical and sports injury recovery
with patented lactoferrin technology for high absorption
How our proprietary lactoferrin technology transforms oral peptide delivery through enhanced protection and targeted absorption.
Lactoferrin's acid-stable coating shields BPC-157 from stomach acid and digestive enzymes, ensuring the peptide remains intact.
Intestinal receptors (LRP1/LRP2) recognize lactoferrin, efficiently transporting the bound peptide directly into intestinal cells for systemic release.
Lactoferrin acts as a carrier protein, prolonging peptide half-life and increasing oral bioavailability by 5x-10x compared to free peptides.
Mucoadhesive properties increase intestinal contact time while supporting gut health for improved peptide transport.
Synapep BPC-157 is available only to podiatrists and licensed-practitioners. To request more information, tap the button below.
Synapep BPC-157 is available from us directly to licensed podiatrist and practitioners. Enter your information below to request more information on the product.
For the fastest response, call us at or send us a text.